Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
Muhammad Anwar Bashir,Amjad Khan,Sayyed Ibrahim Shah,Majeed Ullah,Fazli Khuda,Muhammad Abbas,Khang Wen Goh,Long Chiau Ming
DOI: https://doi.org/10.2147/DDDT.S377686
2023-01-26
Abstract:Muhammad Anwar Bashir, 1 Amjad Khan, 2 Sayyed Ibrahim Shah, 3 Majeed Ullah, 2 Fazli Khuda, 4 Muhammad Abbas, 3 Khang Wen Goh, 5 Long Chiau Ming 6 1 Department of Pharmacy, Abasyn University, Peshawar, Pakistan; 2 Department of Pharmacy, Kohat University of Science and Technology, Kohat, Pakistan; 3 Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan; 4 Department of Pharmacy, University of Peshawar, Peshawar, Pakistan; 5 Faculty of Data Science and Information Technology, INTI International University, Nilai, Malaysia; 6 PAP Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam Correspondence: Khang Wen Goh; Long Chiau Ming, Email ; Background: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant. Methods: The liquids were adsorbed on microcrystalline cellulose, and all developed formulations were compressed using 10.5 mm shallow concave round punches. Results: The resulting tablets were evaluated for different quality-control parameters at pre- and postcompression levels. Simvastatin showed better solubility in a mixture of oils and Tween 60 (10:1). All the developed formulations showed lower self-emulsification time (˂200 seconds) and higher cloud point (˃60°C). They were free of physical defects and had drug content within the acceptable range (98.5%– 101%). The crushing strength of all formulations was in the range of 58– 96 N, and the results of the friability test were within the range of USP (≤ 1). Disintegration time was within the official limits (NMT 15 min), and complete drug release was achieved within 30 min. Conclusion: Using commonly available excipients and machinery, SEDDS-based tablets with better dissolution profile and bioavailability can be prepared by direct compression. These S-SEDDSs could be a better alternative to conventional tablets of simvastatin. Keywords: simvastatin, self-emulsified drug-delivery system, castor oil, olive oil, Tween 60 The oral route of drug administration is not only attractive but is preferred on account of its enhanced patient compliance, better stability, and self-administration, together with flexibility in dose. 1 Unlike sterile products, oral dosage forms need no sterile settings, so production costs are comparatively lower. 2 The major problem with the oral route of drug administration is the poor dissolution rate, especially of Biopharmaceutics Classification System (BCS) class II and IV drugs due to their poor solubility. 3 To cope with this issue, many strategies have been adopted to increase the dissolution and oral bioavailability of drugs, such as structural modification of drugs, development of different drug-delivery systems (DDSs)/drug carriers, reducing particle size, salt formation, and the use of different surfactants, as well as nanoparticles or liposomes. 4 Lipid-based formulations, such as lipid solution, emulsion, and emulsion preconcentrate, and lipid-based nanoparticles are gaining popularity because of their capability to encapsulate a wide range of poorly water-soluble drugs and enhance both dissolution rate and permeation through the gastrointestinal tract (GIT). 3,5 However, their use is limited because of stability issues and manufacturing problems. 6,7 A possible alternative to this is a self-emulsified DDS (SEDDS) in which active pharmaceutical ingredients, lipid (oil), and surfactant form an isotropic mixture, and when mixed with water form an oil-in-water emulsion. 8 Cosolvents and coemulsifiers can also be added to the formulation to increase drug solubility and emulsification. This enables oral administration of hydrophobic drugs in unit dosage form by dissolving in the oil phase and forms a fine emulsion in the presence of GIT fluids, resulting in enhanced dissolution rate and subsequent bioavailability. 9 Droplets of the resultant emulsions are usually in the nanometer to micrometer range. 10 The spontaneously formed emulsion should be stable to dilution with GIT fluids and the drug should remain solubilized for the time sufficient for its absorption. SEDDS technology has been used to increase the solubility and oral bioavailability of many poorly water-soluble drugs, including hydrocortisone, celastrol, indomethacin, and phyllanthin. 11,12 According to Reiss et al, self-emulsification is possib -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal